Decrease of apoptosis rate in patients with renal transplantation treated with mycophenolate mofetil

被引:16
|
作者
Pardo-Mindán, FJ
Errasti, P
Panizo, A
Sola, I
de Alava, E
Lozano, MD
机构
[1] Univ Navarra, Clin Univ, Dept Pathol, E-31080 Pamplona, Spain
[2] Univ Navarra, Clin Univ, Dept Nephrol, E-31080 Pamplona, Spain
来源
NEPHRON | 1999年 / 82卷 / 03期
关键词
mycophenolate mofetil; MIB-1; TUNEL; apoptosis; renal transplantation;
D O I
10.1159/000045407
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Mycophenolate mofetil (MMF) is a powerful immunosuppressant that inhibits the proliferation of lymphocytes by blocking the enzyme inosine monophosphate dehydrogenase. MMF prevents acute graft rejection in organ transplants. The aim of this investigation is to study whether MMF has any influence on apoptosis and proliferation rates of cells other than lymphocytes. Methods:We conducted a retrospective study of renal allograft biopsies taken during the 1st week after transplantation in 25 patients receiving triple therapy with prednisone, ciclosporin and azathioprine 75 mg/day and in 25 patients treated with MMF at a dose of 2 g/day instead of azathioprine,in order to investigate the differences in the proliferation and apoptosis rates of the glomerular, tubular, interstitial and endothelial cells of the kidney. Twelve normal kidneys were used as controls. Conventional histopathological techniques were applied as usual for pathological diagnosis. Proliferative activity was assessed by use of MIB-1 antibody. Sections of formalin-fixed, paraffin-embedded tissue blocks were stained for the presence of apoptotic cells by TUNEL assay. Evaluation of proliferative or apoptotic rates was made by counting the number of positive cells in 10 glomeruli and in 10 transversely cut tubuli in each biopsy. The positive cells in the interstitium were counted in ten high-power fields. Positive cells in the endothelium were scored semiquantitatively from 0 to 3: 0 = none, 1 = isolated cells, 2 = small groups of cells, 3 = most endothelial cells. Mann-Whitney U and chi-square tests were used for intergroup comparisons. Results: All biopsies were normal or had borderline (Banff classification) acute rejection. MIB-1 rates were similar in both groups, without statistical differences (p > 0.05) between them. Significantly lower apoptotic rates were Found in the group treated with MMF in tubular epithelium (23.41 +/- 8.86 vs. 57.4 +/- 13.42; p = 0.021), in glomerular (1.25 +/- 0.78 vs. 5.3 +/- 1.66; p = 0.027), and interstitial cells (1.58 +/- 0.6 vs. 5.8 +/- 1.54; p = 0.043). Apoptosis in endothelial cells (p > 0.05) was similar in both groups. Conclusion: We conclude that treatment with MMF of kidney transplant patients does not affect the proliferative rate of cells of the allograft, bur decreases the number of apoptotic cells in tubular epithelium.
引用
收藏
页码:232 / 237
页数:6
相关论文
共 50 条
  • [31] Combination Therapy of mTOR Inhibitors and Mycophenolate Mofetil in Renal Transplantation
    Demirci, Cenk
    Toz, Huseyin
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2008, 17 : 33 - 38
  • [32] Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation
    Crespo, JF
    Górriz, JL
    Sancho, A
    Avila, A
    Alcoy, E
    Pallardó, LM
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (06) : 2261 - 2262
  • [33] The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation
    Hale, MD
    Nicholls, AJ
    Bullingham, RES
    Hené, R
    Hoitsma, A
    Squifflet, JP
    Weimar, W
    Vanrenterghem, Y
    Van de Woude, FJ
    Verpooten, GA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (06) : 672 - 683
  • [34] Mycophenolate mofetil for renal dysfunction after pediatric liver transplantation
    Evans, HM
    McKiernan, PJ
    Kelly, DA
    TRANSPLANTATION, 2005, 79 (11) : 1575 - 1580
  • [35] Efficacy of mycophenolate mofetil on recurrent glomerulonephritis after renal transplantation
    Harzallah, K
    Badid, C
    Fouque, D
    Lefrancois, N
    Touraine, JL
    Laville, M
    CLINICAL NEPHROLOGY, 2003, 59 (03) : 212 - 216
  • [36] Use of mycophenolate mofetil for prevention of acute rejection in renal transplantation
    Carl, S
    Wiesel, M
    Staehler, G
    UROLOGE-AUSGABE A, 1998, 37 (03): : 282 - 286
  • [37] Long-term benefit of mycophenolate mofetil in renal transplantation
    Lang, P
    Pardon, A
    Audard, V
    TRANSPLANTATION, 2005, 79 (03) : S47 - S48
  • [38] Pharmacokinetics of Mycophenolate Mofetil Metabolites in Older Patients on the Seventh Day After Renal Transplantation
    Sobiak, J.
    Glyda, M.
    Malec, M.
    Chrzanowska, M.
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (07) : 2212 - 2215
  • [39] Mycophenolate mofetil (MMF) oral suspension in pediatric renal transplantation
    Sherbotie, J
    Bunchman, T
    Navarro, M
    Broyer, M
    Chavers, B
    Tonshoff, B
    Grimm, P
    Lemer, G
    Lirenman, D
    Greenbaum, L
    Walker, R
    Zimmerhackl, L
    Blowey, D
    Clark, G
    Ettenger, R
    Ramos, E
    TRANSPLANTATION, 1999, 67 (07) : S125 - S125
  • [40] Mycophenolate mofetil in pediatric renal transplantation: A single center experience
    Raheem, Omer A.
    Kamel, Mohamed H.
    Daly, Padraiq J.
    Mohan, Ponnusamy
    Little, Dilly M.
    Awan, Atif
    Hickey, David P.
    PEDIATRIC TRANSPLANTATION, 2011, 15 (03) : 240 - 244